ID
25724
Description
Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome Concomitant Medication Section (Treatment Phase and Follow-Up)
Keywords
Versions (1)
- 9/12/17 9/12/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 12, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
Description
Concomitant Medication - If Medical History section is included indications on Prior Medication page must correlate utilizing the same terminlogy. Indication on concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology. If a medication was marked continuing at the initial visit (On the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Alias
- UMLS CUI-1
- C2347852
Description
If "YES", please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0443172
Description
Drug Name
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Description
Dose
Data type
text
Alias
- UMLS CUI [1]
- C3174092
Description
Dose Frequency
Data type
text
Alias
- UMLS CUI [1]
- C2826654
Description
Administration Route
Data type
text
Description
Indication
Data type
text
Alias
- UMLS CUI [1]
- C3146298
Description
Start Date - As a minimum the year must be started.
Data type
date
Measurement units
- dd-mmm-yyyy
Description
Start Time
Data type
time
Measurement units
- 24hr:min
Alias
- UMLS CUI [1]
- C1301880
Description
End Date
Data type
date
Measurement units
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0806020
Description
End Time
Data type
time
Measurement units
- 24hr:min
Alias
- UMLS CUI [1]
- C1522314
Description
Ongoing
Data type
boolean
Alias
- UMLS CUI [1]
- C0549178
Similar models
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
C0019994 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])